gens [13] . Chemotherapy, in addition to surgery, has proven to be useful in a number of different cancer types, but not without side effects. Some of these side effects compromise continued treatment, eventually leading to advanced stages of malignancy and mortality. As a result, there is a continued search for more effective and safer anticancer compounds, synthetic, and natural products have been promising in this regard.
The immune cells elicit their protective function against invading microbes and other foreign particles in a process called oxidative burst [14] . The term oxidative burst represents an early event during phagocytosis in which the immune cells generate reactive oxygen species (ROS) in response to soluble agonists [15, 16] . Oxidative burst therefore play a vital role in the host defense mechanism against intruders. However, in chronic inflammation, the overexpressed ROS causes damage to surrounding tissues and is associated with various inflammatory diseases [17] . Therefore, the inhibitors of phagocytes ROS generation can be potential anti-inflammatory agents [18] . Super oxide anion and other oxygen radicals such as hydrogen peroxide, hydroxyl radical, and hypochlorous acid are among the primary mediators of inflammation [17, 19, 20] . Their intracellular levels can be measured by a luminol-amplified chemiluminescence technique, which can be used to assess the immune function as well as to evaluate the anti-inflammatory potential and radical scavenging activity of various chemical and biological agents [21, 22] .
Leishmaniasis is a parasitic protozoan infection caused by more than 20 species of the intracellular parasite Leishmania, with the most notable being Leishmania major, Leishmania mexicana, Leishmania tropica, Leishmania braziliensis, Leishmania donovani, and Leishmania infantum [23] [24] [25] . Though endemic in some tropical and subtropical countries, the disease currently affects more than 12 million people in more than 100 countries [25] [26] [27] . Toxicity and emergence of resistance to current antileishmanial agents is still a major challenge in the effective management of leishmaniasis. For this reason, there is an increasing search for less toxic and more effective alternatives for the management of leishmaniasis [23, 24, 28, 29] . A number of medicinal plants have been investigated and have shown some activity against various forms of the leishmania parasite [30] [31] [32] [33] .
In continuation of our study for the phytochemical and biological investigations of medicinal plants with potential anticancer properties, the methanol extract of C. pulcherrima roots was selected for investigation of cytotoxic activity against three cancer cell lines (MCF-7, HeLa, and PC-3). We report herein the isolation and structure elucidation of the cytotoxic compounds from the active fraction of C. pulcherrima. Cytotoxic activity represents a first step for screening potential bioactive substances. The isolated compounds were further evaluated for their ROS inhibitory as well as leishmanicidal activity.
Results and Discussion
Column chromatographic fractionation of the cytotoxic chloroform extract of C. pulcherrima roots, followed by silica gel column chromatography, preparative TLC, and HPLC, led to the isolation of 10 furanocassane diterpenoids (1-10) (▶ Fig. 1 ). Hydrolysis of 3 yielded 11, and acetylation of 3 and 7 yielded compounds 12 and 13, respectively.
The UV absorptions (λ max at 230.0), IR absorption at 1452-1454 cm −1 , and 1 H-NMR spectra (a pair of doublets at δ 6.12-6.20 and 7.19-7.22, J = 1.5-2.0 Hz) of all of the compounds were characteristic of 2,3-disubstituted furanocassane-type diterpenoids [34] [35] [36] [37] [38] [39] . On the basis of 1D and 2D NMR data, and comparison of 1 H and 13 C-NMR data with the literature, the structures of the compounds were identified as vouacapen-5α-ol (1), ▶ Fig. 1 Chemical structures of compounds 1-13.
8,9,11,14-didehydrovouacapen-5α-ol (2), 6β-cinnamoyl-7β-hydroxyvouacapen-5α-ol (3) [34] , pulcherrin A (4), pulcherrin B (5) [40] , pulcherrin J (6) [41] , pulcherrimin A (7), pulcherrimin B (8), pulcherrimin C (9) [35] , pulcherrimin E (10), 6β-hydroxyisovouacapenol C (11) [4] , 6β-cinnamoyl-7β-acetoxyvouacapen-5α-ol (12) [42] . The 13 C-NMR data of 13 was in agreement with the 1 H-NMR data of pulcherrimin D reported by Patil et al. [35] . The optical rotation of compound 5 was negative, while that reported in literature was positive. This indicated that compound 5 is a levo-isomer of previously reported pulcherrin B. Table 1 ).
Hydrolysis of compound 3 to 11 led to loss of activity against MCF-7 and PC-3 cell lines and a significant reduction in activity against the HeLa cell line. Similarly, compounds without substituents at C-6 and C-7 (compounds 1 and 2) or with only one substitution in either position (compounds 5 and 6) showed little or no cytotoxic activity.
These observations show that substitution at C-6 and C-7 in ring B of the vouacapene nucleus with a benzoyl or cinnamoyl group could be responsible for the observed cytotoxic activity. Compounds with the cinnamoyl substituents (compounds 3, 4, and 12) were more active compared to the benzoyl substituents (compounds 7, 9, and 10). The hydroxyl substituent at C-3 of ring A (compound 7) was found to be more active than the unsubstituted or acetylated counterpart (compounds 9 and 13) against HeLa and PC-3 cell lines, while unsaturation in ring A caused a slight increase in activity (compound 8, IC 50 = 19.13 ± 0.88 µM), and acetylation led to a loss of activity against the MCF-7 cell line (compound 13, IC 50 > 50 µM).
The anti-inflammatory activity of the compounds was evaluated by the oxidative burst assay using a luminol-amplified chemiluminescence technique. Zymosan-stimulated phagocytes elicit a chemiluminescence response in the presence of luminol [43, 44] . Luminol (5-amino-2,3-dihydro-1,4-phthalazindione), being of low molecular weight, can cross the cell membrane and reacts with myeloperoxidase-dependent intracellular oxygen metabolites released during the oxidative burst to form an excited state intermediate, which on relaxation emits light [22] . Presently, the ability of the compounds to suppress the release of ROS was used to assess their anti-inflammatory potential. The results showed that compounds 8 and 13 showed a potent inhibitory effect on oxidative burst with IC 50 values of 15.3 ± 1.1 µM and 8.0 ± ▶ 
Data represent the mean ± SEM of triplicate determination. * Significant difference at p < 0.01 compared to control. Different lower case letters represent a significant difference between the means at p < 0.05. nt = Not tested 0.8 µM, respectively (▶ Table 1 ). The ROS inhibitory activity of 8 and 13 was found to be significantly (p < 0.05) higher than that of the standard anti-inflammatory drug ibuprofen (IC 50 = 54.3 ± 5.3 µM). Compound 9 showed moderate inhibition of ROS (IC 50 = 54.7 ± 4.8 µM. Compounds 8 and 9 have also shown a reducing effect of lipopolysaccharide-stimulated nitric oxide production in murine macrophage RAW 264.7 cell lines [41] . The present findings support the potential of the cassane diterpenoids as anti-inflammatory or immunosuppressive agents. Further research is required to substantiate these findings. Compounds 3, 9, and 13 showed significant leishmanicidal activity with IC 50 values 65.3 ± 3.2, 58.7 ± 2.8, and 55.9 ± 2.4 µM, respectively (▶ Table 1 ).
Materials and Methods

General experimental procedures
Melting points were determined on a capillary melting point apparatus (Buchi). Optical rotations were measured on a PerkinElmer P-2000 polarimeter. IR spectra were recorded on KBr discs on an FTIR-8900 spectrophotometer (Shimadzu). UV spectra were recorded in MeOH on an Evolution 300BB UV-Visible spectrophotometer (Thermo-Scientific). NMR spectra were determined on Bruker Avance AV-300, AV-500, and AV-600 spectrometers in CDCl 3 . Chemical shifts are expressed in parts per million (ppm) using TMS as the internal standard. EI-MS was recorded at an ionizing voltage of 70 eV (direct probe) on a double focusing magnetic sector mass analyzer (JEOL JMS-600H). HPLC was performed using LC-908 recycling preparative HPLC with a normal-phase column (250 × 20 mm) and a UV detector (Japan Analytical Industry Co. Ltd.). Column chromatography was performed using Merck grade silica gel (70-230 mesh). TLC analyses were performed on precoated silica gel 60 F 254 plates. The plates were visualized under UV (254 and 366 nm), and by spraying with ceric sulphate reagent and iodine vapor. 
Plant collection
Extraction and isolation
Air-dried and powdered roots (2.9 kg) of C. pulcherrima Linn. were extracted with methanol (7.5 L) at room temperature for 7 days. The vacuum-dried extract (240 g) was suspended in MeOH : H 2 O (4 : 1), and partitioned into petroleum ether, chloroform, and ethyl acetate soluble fractions by solvent-solvent extraction.
The dried chloroform fraction (87. 34 g ) was rechromatographed on a silica gel column (3 × 65 cm) and eluted with hexane : EtOAc (99 : 1-85 : 15), and the eluates (50 mL each) yielded four subfractions (A1-A4). HPLC purification of A4 (185.2 mg) eluted with iso-octane : EtOAc (8 : 2) at 4 mL/min afforded compound 4 (52 mg, t R = 32 min). Subfraction A3 (42.8 mg) was further purified by column chromatography over silica gel (1 cm×30 Hydrolysis of compound 3: 50 mg of 3 was refluxed with 5 % KOH in MeOH for 3 h. After cooling, the mixture was extracted with CH 2 Cl 2 . The CH 2 Cl 2 extract, on drying, yielded compound 11 (15 mg).
Acetylation of compounds 3 and 7: 50 mg each of compounds 3 and 7 were dissolved separately in a mixture of pyridine and acetic anhydride (2 mL each), and left overnight at room temperature. The resulting products after workup were separated by PTLC, which yielded compounds 12 (32 mg) and 13 (36 mg) from 3 and 7, respectively.
Cytotoxicity (MTT Assay)
Cell culture: Human breast cancer cell line (MCF-7) (ATCC : HTB-22), human cervical cancer cell line (HeLa) (ATCC : CCL-2), and human prostate cancer cell line (ATCC : CRL-1435) were cultured in Dulbeccoʼs modified Eagleʼs medium (MCF-7 and PC-3) and Eagleʼs minimum essential medium (HeLa) at 37°C in a 5 % CO 2 atmosphere. Confluent cells were trypsinized and plated in 96-well tissue culture plates (seeding density 8000 cells/well for MCF-7, 5000 cells/well for HeLa, and 10 000 cells/ well for PC-3) in 100 µL of medium.
Treatment with compounds: After 24 h, compounds were added in triplicate at 50 µM concentrations, and incubated for 48 h. The media was removed and 200 µL of MTT solution (0.5 mg/mL) were added to each well, and incubated at 37°C for 3 h. The formazan crystals formed by the reduction of MTT were dissolved in 100 µL of DMSO and the optical density (O. D.) was measured at 570 nm using a microplate reader (Spectra Max plus, Molecular Devices). Cells without a test compound were used as a control, while the media served as the blank [45] . Doxorubicin (046-21 523, Wako; Purity ≥ 99 % by HPLC) was used as the standard drug.
The percent of inhibition or decrease in cell viability was calculated using the following formula:
Anti-inflammatory activity (oxidative burst assay)
Anti-inflammatory activity of the compounds was evaluated by the oxidative burst assay using a luminol-amplified chemiluminescence technique as previously described with slight modifications [46] . 
Leishmanicidal activity
Leishmania major was obtained from DESTO, and maintained in modified NNN biphasic medium using normal physiological saline. Leishmania parasite promastigotes were cultured in RPMI 1640 medium (Sigma), supplemented with 10 % heat inactivated fetal calf serum (FCS) (PAA Laboratories GmbH). Parasites at the log phase were centrifuged at 2000 rpm for 10 min, and washed three times with saline. Parasites were diluted with fresh culture medium to a final density of 1 × 10 6 cells/mL.
In a 96-well microtiter plate, medium (180 µL) was added in different wells, and 20 µL (250 µg/mL) each of the test compounds were added to the medium in different wells, and serially diluted. Then, 100 µL of parasite culture were added in each well. To serve as a control, medium without a test compound was used. Amphotericin B (MP Biomedical Inc.; purity ≥ 98 % by HPLC) and pentamidine (ICN Biomedical Inc.; purity ≥ 98 % by HPLC) were used as standards. The plates were incubated at 25°C for 72 h. The culture was examined microscopically on a Neubauer counting chamber [47] .
The mortality rate was calculated by the following formula:
Mortality Rateð%Þ ¼ 100 À Number of live cells in test Number of live cells in control Â 100
IC 50 values were calculated using Ezfit 5.03 software (Perella Scientific). All assays were performed in triplicate.
Statistical analysis
Data are expressed as the mean ± S. E. 
Supporting information
Cytotoxic activity of the extract and fractions of C. pulcherrima root bark, 1 H-and 13 C-NMR data of compounds 1-13, and 1 H-NMR spectra of compounds 1-13 are available as supporting information.
